18 January 2021
With the Pacific G10 Macro Rates Team
Last week saw the market re-appraised the odds of tapering in the US, after the FOMC re-emphasised it would be a function of economic resilience. This
was interpreted as a pushback on timing and resulted in the benchmark UST 10yr backing down below 1.10% after touching a 10-month high 1.18%.
11 January 2021
With the Pacific G10 Macro Rates Team
Welcome to the first Pacific G10 Macro weekly for 2021, which continues the madness of 2020 with harsh lockdowns and an attempted “coup” in Washington
DC. The only predictable event was both sides claiming a victory after the eventual resolution of a trade deal on Brexit. Elsewhere positive numbers
were reported from China, Taiwan and South Korea on trade, export, survey and industrial production. These announcements led to a stock indices putting
in healthy returns for the end of year and a relatively limited response from government bonds.
04 January 2021
CIO Monthly View with Will Bartleet, CIO and multi-asset portfolio manager at Pacific Asset Management
Equity markets
rounded off an extraordinary year with gains in most markets. The global roll out of the vaccine for COVID-19 began in the UK, which was the first
country to approve the Pfizer/BioNTech vaccine. The UK’s Medicines and Healthcare products Regulatory Agency also approved the AstraZeneca/Oxford University
vaccine which has the advantage of being able to be stored in a conventional refrigerator, easing the distribution challenges of the Pfizer and Moderna
vaccines.
1